2-6865669-C-G

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate

The NM_207315.4(CMPK2):ā€‹c.28G>Cā€‹(p.Gly10Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000237 in 1,307,534 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā˜…).

Frequency

Genomes: š‘“ 0.000072 ( 0 hom., cov: 35)
Exomes š‘“: 0.000017 ( 0 hom. )

Consequence

CMPK2
NM_207315.4 missense

Scores

1
1
17

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -2.33
Variant links:
Genes affected
CMPK2 (HGNC:27015): (cytidine/uridine monophosphate kinase 2) This gene encodes one of the enzymes in the nucleotide synthesis salvage pathway that may participate in terminal differentiation of monocytic cells. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2012]
RSAD2 (HGNC:30908): (radical S-adenosyl methionine domain containing 2) The protein encoded by this gene is an interferon-inducible antiviral protein that belongs to the S-adenosyl-L-methionine (SAM) superfamily of enzymes. The protein plays a role in cellular antiviral response and innate immune signaling. Antiviral effects result from inhibition of viral RNA replication, interference in the secretory pathway, binding to viral proteins and dysregulation of cellular lipid metabolism. The protein has been found to inhibit both DNA and RNA viruses, including influenza virus, human immunodeficiency virus (HIV-1) and Zika virus. [provided by RefSeq, Sep 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.030071676).
BP6
Variant 2-6865669-C-G is Benign according to our data. Variant chr2-6865669-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 2528602.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CMPK2NM_207315.4 linkc.28G>C p.Gly10Arg missense_variant 1/5 ENST00000256722.10 NP_997198.2 Q5EBM0-1
CMPK2NM_001256477.1 linkc.28G>C p.Gly10Arg missense_variant 1/4 NP_001243406.1 Q5EBM0-4
CMPK2NM_001256478.1 linkc.28G>C p.Gly10Arg missense_variant 1/4 NP_001243407.1 Q5EBM0-3
CMPK2NR_046236.2 linkn.210+757G>C intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CMPK2ENST00000256722.10 linkc.28G>C p.Gly10Arg missense_variant 1/51 NM_207315.4 ENSP00000256722.5 Q5EBM0-1

Frequencies

GnomAD3 genomes
AF:
0.0000725
AC:
11
AN:
151792
Hom.:
0
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00174
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000173
AC:
20
AN:
1155634
Hom.:
0
Cov.:
38
AF XY:
0.0000179
AC XY:
10
AN XY:
559212
show subpopulations
Gnomad4 AFR exome
AF:
0.0000436
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000307
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000114
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000724
AC:
11
AN:
151900
Hom.:
0
Cov.:
35
AF XY:
0.0000538
AC XY:
4
AN XY:
74282
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.0000655
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00175
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000227

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsMay 17, 2023This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
0.089
DANN
Benign
0.80
DEOGEN2
Benign
0.011
.;T;.
Eigen
Benign
-2.1
Eigen_PC
Benign
-2.1
FATHMM_MKL
Benign
0.16
N
LIST_S2
Benign
0.47
T;T;T
M_CAP
Pathogenic
0.31
D
MetaRNN
Benign
0.030
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.34
N;N;N
PrimateAI
Uncertain
0.77
T
PROVEAN
Benign
0.010
N;N;N
REVEL
Benign
0.0070
Sift
Benign
0.22
T;T;T
Sift4G
Benign
0.10
T;T;T
Polyphen
0.0040
B;B;.
Vest4
0.069
MutPred
0.27
Loss of methylation at R9 (P = 0.0349);Loss of methylation at R9 (P = 0.0349);Loss of methylation at R9 (P = 0.0349);
MVP
0.13
MPC
0.40
ClinPred
0.057
T
GERP RS
-3.3
Varity_R
0.061
gMVP
0.22

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1177343001; hg19: chr2-7005800; API